QQ客服 官方微博 反馈留言

	An ERCC4 regulatory variant predicts grade-3 or-4 toxicities in patients with advanced non-small cell lung cancer treated by platinum-based therapy
	Zhang, Ruoxin; Jia, Ming; Xu, Yuan; Qian, Danwen; Wang, Mengyun; Zhu, Meiling; Sun, Menghong; Chang, Jianhua; Wei, Qingyi
刊名	INTERNATIONAL JOURNAL OF CANCER
	2018
卷号	142期号:6
关键词	non-small cell lung cancer platinum-based chemotherapy nucleotide excision repair pathway regulatory single nucleotide polymorphism grade 3/4 toxicity
ISSN号	0020-7136
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3603290
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Zhang, Ruoxin,Jia, Ming,Xu, Yuan,et al. An ERCC4 regulatory variant predicts grade-3 or-4 toxicities in patients with advanced non-small cell lung cancer treated by platinum-based therapy[J]. INTERNATIONAL JOURNAL OF CANCER,2018,142(6).
APA	Zhang, Ruoxin.,Jia, Ming.,Xu, Yuan.,Qian, Danwen.,Wang, Mengyun.,...&Wei, Qingyi.(2018).An ERCC4 regulatory variant predicts grade-3 or-4 toxicities in patients with advanced non-small cell lung cancer treated by platinum-based therapy.INTERNATIONAL JOURNAL OF CANCER,142(6).
MLA	Zhang, Ruoxin,et al."An ERCC4 regulatory variant predicts grade-3 or-4 toxicities in patients with advanced non-small cell lung cancer treated by platinum-based therapy".INTERNATIONAL JOURNAL OF CANCER 142.6(2018).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。